Lithium Carbonate, Haloperidol, and Irreversible Brain Damage

Wendy J. Cohen

JAMA · 1974 · 395 citations · 16 references

Concepts

TL;DR

Four acutely agitated manic patients were treated with a combined regimen of lithium carbonate and high‑dose haloperidol, a therapy previously used at Metropolitan Hospital without reported adverse effects. All four patients developed severe encephalopathic syndromes, including lethargy, fever, tremor, confusion, extrapyramidal and cerebellar dysfunction, leukocytosis, elevated serum enzymes, BUN, and glucose; two suffered irreversible brain damage and two had persistent dyskinesias, with no causal factors identified. JAMA 230:1283‑1287 (1974).

Abstract

Four acutely agitated patients with diagnoses of mania were treated with a combined regimen of lithium carbonate and high doses of haloperidol—a form of therapy that had been used previously in Metropolitan Hospital without reported adverse effects. In these four, severe encephalopathic syndromes developed. Symptoms consisted of lethargy, fever, tremulousness, confusion, and extrapyramidal and cerebellar dysfunction, accompanied by leukocytosis and elevated levels of serum enzymes, blood urea nitrogen, and fasting blood glucose. Two patients suffered widespread, devastating, irreversible brain damage. Two others were left with persistent dyskinesias. Causal factors have not been identified. (<i>JAMA</i>230:1283-1287, 1974)

References

16